Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Abbott
MedTech
Insulet, Abbott, Dexcom set sights on Type 2 diabetes at ATTD
Three diabetes tech companies made the case in Barcelona for their CGMs and insulin pumps as they look to expand their reach in Type 2 diabetes.
Conor Hale
Mar 12, 2026 1:07pm
Newly minted MiniMed nets CE mark for 780G pump, Instinct CGM
Mar 11, 2026 10:05am
NICE greenlights Abbott's cardiac sensor implant for NHS
Feb 6, 2026 5:45am
Abbott hit by quality violations from FDA over CGM products
Feb 4, 2026 9:25am
Abbott, AtaCor team up on extravascular defibrillator implant
Jan 20, 2026 6:45am
Abbott launches AI-based Libre Assist
Jan 5, 2026 10:10am
